Search alternatives:
significant consent » significant concerns (Expand Search), significant concern (Expand Search), significant component (Expand Search)
consent increased » content increased (Expand Search), contents increased (Expand Search), content increases (Expand Search)
gap decrease » gain decreased (Expand Search), mean decrease (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 161 - 180 results of 74,473 for search '(( significant ((gap decrease) OR (a decrease)) ) OR ( significant consent increased ))', query time: 1.60s Refine Results
  1. 161
    Image_1_1,800 MHz Radiofrequency Electromagnetic Irradiation Impairs Neurite Outgrowth With a Decrease in Rap1-GTP in Primary Mouse Hippocampal Neurons and Neuro2a Cells.pdf

    Image_1_1,800 MHz Radiofrequency Electromagnetic Irradiation Impairs Neurite Outgrowth With a Decrease in Rap1-GTP in Primary Mouse Hippocampal Neurons and Neuro2a Cells.pdf by Yanqi Li (3395705)

    Published 2021
    “…Rap1, Rap1a, Rap1b, Rap1GAP, and p-MEK1/2 protein expressions were detected by western blot. …”
    Save to List
    Saved in:
  2. 162
    Flowchart of the inclusion and exclusion criteria.

    Flowchart of the inclusion and exclusion criteria. by Toru Hosokawa (364158)

    Published 2023
    Save to List
    Saved in:
  3. 163
    CircAGFG1 absence decreases PKM2 expression to enhance oxaliplatin sensitivity in colorectal cancer in a miR-7-5p-dependent manner

    CircAGFG1 absence decreases PKM2 expression to enhance oxaliplatin sensitivity in colorectal cancer in a miR-7-5p-dependent manner by Jun Chen (4238)

    Published 2023
    “…The effect of circAGFG1 on L-OHP sensitivity <i>in vivo</i> was further evaluated by a xenograft model assay. CircAGFG1 and PKM2 expression were significantly increased, while miR-7-5p was decreased in L-OHP-resistant CRC tissues and cells. …”
    Save to List
    Saved in:
  4. 164
    HPV16 E1 decreases cell growth.

    HPV16 E1 decreases cell growth. by Fern Baedyananda (11888703)

    Published 2021
    Save to List
    Saved in:
  5. 165
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  6. 166
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  7. 167
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  8. 168
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  9. 169
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  10. 170
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  11. 171
    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  12. 172
    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  13. 173
    Wage gaps by gender, sector and year.

    Wage gaps by gender, sector and year. by Mingming Li (502877)

    Published 2024
    “…<div><p>Although the Chinese government has implemented a variety of measures, the gender wage gap in 21<sup>st</sup> century China has not decreased. …”
    Save to List
    Saved in:
  14. 174
    Number and % of participants demonstrating a clinically-significant difference on RMSSD HRV (comparing compassion or relaxation task to control).

    Number and % of participants demonstrating a clinically-significant difference on RMSSD HRV (comparing compassion or relaxation task to control). by Iona Naismith (14581268)

    Published 2023
    Save to List
    Saved in:
  15. 175
    Depletion of TbSWR1 caused a decrease of reporter luciferase activity within a PTU.

    Depletion of TbSWR1 caused a decrease of reporter luciferase activity within a PTU. by Tim Vellmer (12837414)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 176
    Decrease of apolipoprotein-A1 by gender and age in US cohort.

    Decrease of apolipoprotein-A1 by gender and age in US cohort. by Thierry Poynard (38084)

    Published 2020
    Save to List
    Saved in:
  17. 177
    Predictors of IPV among mothers.

    Predictors of IPV among mothers. by Sawsan Abuhammad (9657340)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 178
    Predictors of HRQoL among mothers.

    Predictors of HRQoL among mothers. by Sawsan Abuhammad (9657340)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 179
    Demographic of participants in Jordan (N = 300).

    Demographic of participants in Jordan (N = 300). by Sawsan Abuhammad (9657340)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 180
    S1 Data -

    S1 Data - by Sawsan Abuhammad (9657340)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: